Exabis Library
Welcome to the e-CCO Library!
P616: Fatigue in pediatric inflammatory bowel diseases – systematic review and rates in a prospective cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P616: Natural history and phenotype of inflammatory bowel disease with co-existent celiac disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P616: Safety of COVID-19 vaccines in patients with IBD
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P616: Sustainability of thiopurines monotherapy in ulcerative colitis: a nationwide analysis from the epi-IIRN cohort
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P616: Ustekinumab for refractory paediatric Crohn’s disease: experience from two UK tertiary referral centres
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P616: Utility of zinc protoporphyrin/haem ratio as a marker of iron deficiency with or without anaemia in patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P617 Mesenchymal stromal cells of bone marrow reduce the risk of postoperative recurrence of Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P617: Dual biologic therapy in pediatric Inflammatory Bowel Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P617: Evaluation of subclinical myocardial damage in patients with inflammatory bowel disease on treatment with biologics
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P617: Extraintestinal autoimmune phenomena during treatment with vedolizumab
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P617: Single-centre experience with biological treatment in budesonide-refractory microscopic colitis patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P617: Switching from an intensified regimen of infliximab to a subcutaneous standard dose in adults with Inflammatory Bowel Disease: our experience in a tertiary hospital.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P617: Trends in Pediatric Inflammatory Bowel Disease-attributable direct costs: A Canadian population-based analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618 Post-operative Crohn’s disease patients undergoing colonoscopy require significantly more analgesia and sedation compared with a non-IBD population
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P618: Long-term real-world data of Ustekinumab in Ulcerative Colitis – the Stockholm Ustekinumab study – STOCUSTE
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P618: Post-operative pain following laparoscopic right hemicolectomy for Crohn’s disease a comparative study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P618: Pre-operative oral enteral nutritional optimisation for Crohn’s disease: A retrospective UK tertiary IBD centre cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P618: Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P618: Treatment outcomes of patients with Crohn’s disease and complex perianal fistula in five European countries: the PREFACE retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P618: Vedolizumab acute infusion reactions in inflammatory bowel disease patients: results of a multi-centre retrospective observational cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM